GlassScriptPhysician profile
Cheryl A Koch
NPI 1790707198
$12,341.00
in general payments reported to CMS, 2019-2025
61 companies · $2,912 in 2025
The $2,912 reported for 2025 was more than what 83% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $339 · 2021: $210 · 2022: $1,830 · 2023: $2,354 · 2024: $3,610 · 2025: $2,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,050 · Travel and Lodging: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,049.68 |
| Travel and Lodging | $827.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,673.54 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Medtronic, INC. | $1,498.93 | 2022-2025 | Minimed 780g |
| Novo Nordisk INC | $1,175.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $904.79 | 2019-2025 | Freestyle Libre 3 |
| Amgen INC. | $858.59 | 2019-2025 | Evenity, Prolia, Tepezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $754.85 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Sanofi-Aventis U.S. LLC | $495.32 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $324.00 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $303.32 | 2020-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $296.86 | 2019-2025 | |
| Ibsa Pharma INC. | $294.16 | 2019-2025 | Tirosint, Tirosint, Licart |
| Xeris Pharmaceuticals, INC. | $289.40 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Astrazeneca Pharmaceuticals LP | $271.69 | 2019-2025 | Farxiga |
| Radius Health, INC. | $261.26 | 2022-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $241.54 | 2021-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $202.15 | 2022-2024 | Korlym |
| Insulet Corporation | $171.97 | 2019-2025 | Omnipod |
| Tolmar, INC. | $165.02 | 2023-2025 | Jatenzo |
| Pfizer INC. | $155.95 | 2019-2025 | |
| Kyowa Kirin, INC. | $152.02 | 2023-2025 | Crysvita |
| Amphastar Pharmaceuticals, INC. | $147.00 | 2023-2025 | Baqsimi |
| Becton, Dickinson and Company | $145.86 | 2019-2022 | |
| Mannkind Corporation | $140.05 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $106.56 | 2022-2024 | |
| Amarin Pharma, INC. | $102.30 | 2019-2022 | |
| Cequr Corporation | $75.03 | 2023-2024 | Cequr Simplicity |
| Merck Sharp & Dohme LLC | $63.28 | 2019 | |
| Astellas Pharma US INC | $57.59 | 2024-2025 | Veozah |
| Soleno Therapeutics, INC. | $55.44 | 2025 | Vykat Xr |
| Beta Bionics, INC. | $54.34 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ultragenyx Pharmaceutical INC. | $51.39 | 2019-2023 | Crysvita |
| Verity Pharmaceuticals INC. | $49.26 | 2024-2025 | Tlando |
| Sequel Med Tech, LLC | $46.37 | 2025 | Twiist |
| Ipsen Biopharmaceuticals, INC | $44.19 | 2022-2023 | Somatuline Depot |
| Antares Pharma, INC. | $43.20 | 2019-2020 | |
| Averitas Pharma INC. | $40.76 | 2023-2024 | Qutenza |
| Companion Medical, INC. | $40.08 | 2019 | |
| Horizon Therapeutics Plc | $39.34 | 2023 | Tepezza |
| Ascensia Diabetes Care US INC. | $38.94 | 2022-2023 | |
| Almatica Pharma LLC | $36.75 | 2024-2025 | Teriparatide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.65 | 2022-2023 | Cycloset |
| Alexion Pharmaceuticals, INC. | $35.55 | 2019-2023 | Strensiq |
| Recordati_rare_diseases_inc. | $31.95 | 2024 | Signifor Lar, Isturisa |
| Embecta Corp. | $26.29 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Ascendis Pharma Endocrinology INC | $26.07 | 2023 | |
| Glaxosmithkline, LLC. | $25.88 | 2025 | Shingrix, Arexvy |
| Bigfoot Biomedical INC | $24.76 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $23.83 | 2025 | Imcivree |
| Zealand Pharma US, INC. | $23.70 | 2022 | |
| Madrigal Pharmaceuticals | $23.50 | 2025 | Rezdiffra |
| Alfasigma USA, INC. | $21.74 | 2020 | |
| Clarus Therapeutics INC. | $21.40 | 2021 | |
| Nevro Corp. | $20.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.14 | 2019 | |
| Evoke Pharma, INC. | $18.79 | 2025 | |
| Amneal Pharmaceuticals LLC | $18.40 | 2025 | Unithroid |
| Acella Pharmaceuticals, LLC | $16.21 | 2025 | NP Thyroid 60 |
| Amryt Pharma Holdings LTD | $15.58 | 2023 | Mycapssa |
| Medtronic Minimed, INC. | $15.47 | 2020 | |
| Intra-Sana Laboratories | $14.82 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Lifescan, INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.